Skip to menu Skip to content Skip to footer

Complement C3a receptor, a novel therapeutic target for melanoma (2014-2015)

Experts

Associate Professor Barbara Rolfe

Principal Research Fellow and GL
Australian Institute for Bioengineering and Nanotechnology
Principal Research Fellow and Group
Australian Institute for Bioengineering and Nanotechnology
Barbara Rolfe
Barbara Rolfe

Professor Andrew Barbour

Professor
Princess Alexandra Hospital Southside Clinical Unit
Faculty of Medicine
Affiliate Professor of Frazer Insti
Frazer Institute
Faculty of Medicine
Andrew Barbour
Andrew Barbour